Commonwealth Equity Services
HQL

Commonwealth Equity Services’s abrdn Life Sciences Investors HQL Stock Holding History

Commonwealth Equity Services’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$346K Sell
21,253
-4,373
-17% -$73.1K ﹤0.01% 3548
2025
Q4 		$430K Sell
25,626
-7,369
-22% -$124K ﹤0.01% 3304
2025
Q3 		$512K Sell
32,995
-172
-0.5% -$2.35K ﹤0.01% 3153
2025
Q2 		$425K Buy
33,167
+4,045
+14% +$49.9K ﹤0.01% 3295
2025
Q1 		$370K Sell
29,122
-997
-3% -$13.5K ﹤0.01% 3300
2024
Q4 		$395K Buy
30,119
+933
+3% +$13.5K ﹤0.01% 3166
2024
Q3 		$440K Sell
29,186
-4,602
-14% -$69.6K ﹤0.01% 2997
2024
Q2 		$479K Buy
33,788
+868
+3% +$11.7K ﹤0.01% 2870
2024
Q1 		$449K Sell
32,920
-87
-0.3% -$1.2K ﹤0.01% 2909
2023
Q4 		$444K Sell
33,007
-5,866
-15% -$72.2K ﹤0.01% 2820
2023
Q3 		$485K Sell
38,873
-6,315
-14% -$83.1K ﹤0.01% 2622
2023
Q2 		$612K Sell
45,188
-14,651
-24% -$202K ﹤0.01% 2451
2023
Q1 		$833 Sell
59,839
-1,192
-2% -$17K ﹤0.01% 2172
2022
Q4 		$867K Buy
61,031
+1,354
+2% +$19.6K ﹤0.01% 2058
2022
Q3 		$815K Sell
59,677
-1,330
-2% -$19.9K ﹤0.01% 2044
2022
Q2 		$868K Sell
61,007
-2,838
-4% -$42.9K ﹤0.01% 2011
2022
Q1 		$1.06M Buy
63,845
+12,292
+24% +$212K ﹤0.01% 1955
2021
Q4 		$991K Buy
51,553
+4,847
+10% +$97.5K ﹤0.01% 1996
2021
Q3 		$971K Buy
46,706
+7,432
+19% +$159K ﹤0.01% 1946
2021
Q2 		$842K Sell
39,274
-2,394
-6% -$48.3K ﹤0.01% 2049
2021
Q1 		$821K Buy
41,668
+8,231
+25% +$170K ﹤0.01% 1940
2020
Q4 		$660K Buy
33,437
+3,039
+10% +$56.2K ﹤0.01% 1944
2020
Q3 		$534K Sell
30,398
-3,104
-9% -$55.6K ﹤0.01% 1921
2020
Q2 		$601K Sell
33,502
-1,173
-3% -$20.1K ﹤0.01% 1758
2020
Q1 		$519K Sell
34,675
-3,438
-9% -$56.3K ﹤0.01% 1668
2019
Q4 		$664K Buy
38,113
+40
+0.1% +$656 ﹤0.01% 1690
2019
Q3 		$574K Buy
38,073
+13,053
+52% +$209K ﹤0.01% 1729
2019
Q2 		$421K Sell
25,020
-1,584
-6% -$26.1K ﹤0.01% 1925
2019
Q1 		$455K Sell
26,604
-1,602
-6% -$27.7K ﹤0.01% 1820
2018
Q4 		$426K Sell
28,206
-10,253
-27% -$181K ﹤0.01% 1754
2018
Q3 		$785K Sell
38,459
-3,531
-8% -$70.2K ﹤0.01% 1465
2018
Q2 		$789K Buy
41,990
+2,748
+7% +$51.7K ﹤0.01% 1431
2018
Q1 		$754K Buy
39,242
+320
+0.8% +$6.41K ﹤0.01% 1411
2017
Q4 		$764K Buy
38,922
+204
+0.5% +$4.09K ﹤0.01% 1388
2017
Q3 		$832K Sell
38,718
-1,435
-4% -$30.5K 0.01% 1288
2017
Q2 		$837K Sell
40,153
-3,344
-8% -$67.6K 0.01% 1241
2017
Q1 		$843K Sell
43,497
-1,031
-2% -$19.1K 0.01% 1204
2016
Q4 		$757K Sell
44,528
-3,871
-8% -$68K 0.01% 1172
2016
Q3 		$907K Buy
48,399
+2,473
+5% +$46.6K 0.01% 1059
2016
Q2 		$789K Sell
45,926
-1,318
-3% -$24.3K 0.01% 1103
2016
Q1 		$848K Sell
47,244
-1,421
-3% -$25.8K 0.01% 1032
2015
Q4 		$1.15M Buy
48,665
+4,797
+11% +$119K 0.01% 861
2015
Q3 		$987K Buy
43,868
+13,277
+43% +$372K 0.01% 899
2015
Q2 		$863K Buy
30,591
+3,549
+13% +$98.4K 0.01% 1035
2015
Q1 		$746K Buy
27,042
+2,070
+8% +$56.4K 0.01% 1112
2014
Q4 		$621K Sell
24,972
-22,029
-47% -$529K 0.01% 1147
2014
Q3 		$1.04M Buy
47,001
+16,234
+53% +$353K 0.01% 851
2014
Q2 		$639K Buy
30,767
+13,763
+81% +$289K 0.01% 1099
2014
Q1 		$370K Buy
17,004
+6,186
+57% +$138K 0.01% 1347
2013
Q4 		$221K Buy
+10,818
New +$210K ﹤0.01% 1645

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Commonwealth Equity Services's HQL Position: Q1 2026 in Review

Commonwealth Equity Services reduced its abrdn Life Sciences Investors (HQL) stake by 17% in Q1 2026, selling an estimated $73.1K and leaving 21,253 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #3548.

Commonwealth Equity Services first reported a position in HQL in Q4 2013 and has held it in 50 quarters since. The position peaked at $1.15M in Q4 2015. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Commonwealth Equity Services held 21,253 shares of abrdn Life Sciences Investors worth $346K as of Q1 2026.
  • Commonwealth Equity Services sold 4,373 abrdn Life Sciences Investors shares in Q1 2026, an estimated $73.1K.
  • abrdn Life Sciences Investors made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #3548 holding.
  • Commonwealth Equity Services first reported a position in abrdn Life Sciences Investors in Q4 2013 and has held it in 50 quarters since.
  • Commonwealth Equity Services's abrdn Life Sciences Investors position peaked at $1.15M in Q4 2015.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.